Providence Medical Technology closed a US $10.5MM new equity financing round. Proceeds will support commercialization and expansion of cervical fusion products. Previous fundings included $6.8MM in 2014 and $12.0MM in 2015.
The company’s line includes DTRAX® spinal systems, CAVUX™ cervical cages, ALLY™ screw systems and BIOLOGIX™ allograft bone, provided in single-use sterile packaging.
Participants included new investor MVM Life Science Partners leading the transaction, accompanied by Stanmore Medical Investments, Aphelion Capital and existing private investors.
Providence Medical Technology closed a US $10.5MM new equity financing round. Proceeds will support commercialization and expansion of cervical fusion products. Previous fundings included $6.8MM in 2014 and $12.0MM in 2015.
The company's line includes DTRAX® spinal systems, CAVUX™ cervical cages, ALLY™ screw systems and BIOLOGIX™ allograft...
Providence Medical Technology closed a US $10.5MM new equity financing round. Proceeds will support commercialization and expansion of cervical fusion products. Previous fundings included $6.8MM in 2014 and $12.0MM in 2015.
The company’s line includes DTRAX® spinal systems, CAVUX™ cervical cages, ALLY™ screw systems and BIOLOGIX™ allograft bone, provided in single-use sterile packaging.
Participants included new investor MVM Life Science Partners leading the transaction, accompanied by Stanmore Medical Investments, Aphelion Capital and existing private investors.
Copy to clipboard 
